---
title: "Top 10 US Stock Gainers (3.9)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278452453.md"
description: "Relmada Therapeutics(RLMD) rose 61.12%, with a trading turnover 277.6 Million USD, and a year-to-date rose 48.4%. Xenon Pharma(XENE) rose 49.64%, with a trading turnover 700.9 Million USD, and a year-to-date rose 40%. Hims & Hers Health(HIMS) rose 40.79%, with a trading turnover 3.9 Billion USD, and a year-to-date fell 31.8%."
datetime: "2026-03-09T22:00:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278452453.md)
  - [en](https://longbridge.com/en/news/278452453.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278452453.md)
---

# Top 10 US Stock Gainers (3.9)

NASDAQ Composite Index has rose 1.38%, with a year-to-date fell 2.3%; S&P 500 has rose 0.83%, with a year-to-date fell 0.7%; Dow Jones Industrial Average has rose 0.5%, with a year-to-date fell 0.7%.

Relmada Therapeutics(RLMD) rose 61.12%, with a trading turnover 277.6 Million USD, and a year-to-date rose 48.4%.

Xenon Pharma(XENE) rose 49.64%, with a trading turnover 700.9 Million USD, and a year-to-date rose 40%.

Hims & Hers Health(HIMS) rose 40.79%, with a trading turnover 3.9 Billion USD, and a year-to-date fell 31.8%.

### Related Stocks

- [RLMD.US](https://longbridge.com/en/quote/RLMD.US.md)
- [XENE.US](https://longbridge.com/en/quote/XENE.US.md)
- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [QURE.US](https://longbridge.com/en/quote/QURE.US.md)
- [DNTH.US](https://longbridge.com/en/quote/DNTH.US.md)
- [AXTI.US](https://longbridge.com/en/quote/AXTI.US.md)
- [DYN.US](https://longbridge.com/en/quote/DYN.US.md)
- [KC.US](https://longbridge.com/en/quote/KC.US.md)
- [AAOI.US](https://longbridge.com/en/quote/AAOI.US.md)
- [AEHR.US](https://longbridge.com/en/quote/AEHR.US.md)

## Related News & Research

- [Xenon Pharmaceuticals to present at Bloom Burton healthcare investor conference](https://longbridge.com/en/news/282844842.md)
- [Kingsoft Cloud Reports Stable Share Capital and Public Float in March 2026 Hong Kong Filing](https://longbridge.com/en/news/282199563.md)
- [Hims & Hers' Shift to Branded Obesity Drugs Pressures Stock — Will the Bet Pay Off?](https://longbridge.com/en/news/282190695.md)
- [Dianthus Therapeutics (NASDAQ:DNTH) EVP Ryan Savitz Sells 8,224 Shares](https://longbridge.com/en/news/282414029.md)
- [Citron Calls Applied Optoelectronics' Valuation 'Delusional'](https://longbridge.com/en/news/282372915.md)